Just one more day until Joe Nabhan will be speaking about our engineered #ARMMs platform at the Next Generation Gene Therapy Vectors Summit!
Our CSO, Joe Nabhan, will be speaking at the 4th?Next Generation Gene Therapy Vectors Summit (June 12-14, Boston) about recent advances made to our engineered #ARMMs platform.
Gain insights into the current top challenges in #CellandGeneTherapy and their solutions from Pierre Springuel at this year's #ESACT2024 . Learn more about Sartorius cell and gene therapy solutions: https://sar.to/cxfym #SimplifyingProgress #InThisTogether #AdvancedTherapies
Cell & Gene Therapy ?? Skills & Training | Business Development | #CommunityBuilding ?? Let’s connect??
???????? The Cell and Gene Therapy Catapult Annual Review 2024 is available ?? ?? Some key considerations are highlighted below that are critical to the continued success of the sector. Fantastic to see key programmes within the organisations focusing on these areas. Lots of work to do in this exciting sector. #manufacturing, #automation, #digitalisation, #skills, #clinicaltrials
Take a look at the Cell and Gene Therapy Catapult Annual Review 2024 to learn more about how the UK #AdvancedTherapy industry has progressed, and how we can continue to drive its growth in the future. ?? https://buff.ly/47S8Veo Learn more ?? #CellTherapy #GeneTherapy #ATMP
Frederic Revah, CEO of Genethon, discusses Duchenne muscular dystrophy, the organization’s efforts to complete clinical development of its gene therapy for the condition, and how it might commercialize the treatment. Global Genes https://lnkd.in/gmj7vQjg
Frederic Revah, CEO of Genethon, discusses Duchenne muscular dystrophy, the organization’s efforts to complete clinical development of its gene therapy for the condition, and how it might commercialize the treatment. Global Genes https://lnkd.in/ga-MuV98
McKesson issued its 2024 Cell and Gene Therapy report last week. One theme was the idea that limited Centers of Excellence / Qualified Treatment Centers leads to limited awareness and access, especially in the onology space. Knowing that every report serves its own agenda, it's worth a thumb through (you know where to look for access - they want your data before you can download and I don't want to steal their thunder by posting whole report). #cgt #genetherapy #atmp #celltherapy #CAR-T
How is investment in the cell and gene therapy sector shaping up this year? Our data shows that through the first half of 2024, there have been over $11 billion in deals, approaching the annual total for 2023. Dive into ARM's full quarterly data on investments, clinical trials, and total developers on our website. ?? https://lnkd.in/ebVuvmKK #cellandgenetherapy #data
Curious about the evolving landscape of Cell and Gene Therapy (#CAGT)? Kick-start your journey with the first part of our CAGT webinar series. Join us as our SMEs explore the #regulatory and #clinicaldevelopment challenges, operational models, and strategies for making critical clinical development decisions, driving CAGT innovation forward. Register now: https://bit.ly/3ZIrDl8
Did you see we recently released our 2024 Cell and Gene Therapy Catapult Good Manufacturing Practice (GMP) Report? ?? https://ow.ly/nUey50UaNow Watch the video to see highlights from this year's report and head over to our website to learn more. #CellTherapy #GeneTherapy #AdvancedTherapies #ATMPs?
Gain insights into the current top challenges in cell and gene therapy and their solutions from Catherine BUCHERE at this year's ESACT. Learn more about Sartorius cell and gene therapy solutions: https://sar.to/0i1cj #SimplifyingProgress #InThisTogether #AdvancedTherapies #CellandGeneTherapy #ESACT #ESACT2024
Microbiology Account Executive | Microbiology & Infection Diagnostics at Bruker Scientific, LLC
??Are you attending #ASGCT and are eager to revolutionize your AAV analysis? Swing by Booth 2228 and visit my colleague Andrew Newton to discuss how the #LabChip GXII Touch can help 'Revv' up your AAV development! ?? The LabChip GXII Touch system can make #AAV characterization easier. Our system streamlines your AAV characterization, saving you time and effort. The integrated approach minimizes errors and technical glitches, leading to more reliable results. You can analyze up to 96 samples per run with rapid, microfluidic capillary electrophoresis. ? Get a complete picture of your AAV capsids in minutes: ? Partials estimation ? Purity assessment of viral proteins ? Genomic integrity of genomic insert (#ssDNA) ? Purity of genomic insert ? Sizing of genomic insert ? AAV empty full analysis data ? Expected viral protein egrams Come by and see how this system can help you! #revvity #WeAreRevvity #UnitedinImpact #UnitedinScience #InnovationUnleashed #LabchipGXIITouch #microfluidics #microfluidic #capillaryelectrophoresis #highthroughput #lifescience #biotech #biotechnology #biopharma #biopharmaceuticals #protein #nucleicacid #cellandgenetherapy #cgt #mRNA #proteomics #genomics #biochemistry #molecularbiology #innovation #labequipment #proteinanalysis #drugdiscovery #drugdevelopment #researchanddevelopment #gmp #aav #lnp
?? Booth #2228 is where the future of gene therapy takes shape! Join us at #ASGCT2024 in Baltimore to experience how Revvity is pushing the boundaries of scientific innovation. Don't miss out — your next breakthrough could start with a conversation at our booth!
